1. Home
  2. IRWD vs BBSI Comparison

IRWD vs BBSI Comparison

Compare IRWD & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.84

Market Cap

663.6M

Sector

Health Care

ML Signal

HOLD

Logo Barrett Business Services Inc.

BBSI

Barrett Business Services Inc.

HOLD

Current Price

$29.60

Market Cap

748.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRWD
BBSI
Founded
1998
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
663.6M
748.3M
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
IRWD
BBSI
Price
$4.84
$29.60
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$7.67
$42.67
AVG Volume (30 Days)
1.8M
137.1K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
1.01%
EPS Growth
1400.00
5.05
EPS
0.15
2.08
Revenue
$298,276,000.00
$920,432,000.00
Revenue This Year
$57.95
$6.59
Revenue Next Year
$4.39
$6.05
P/E Ratio
$31.07
$14.57
Revenue Growth
8.88
9.50
52 Week Low
$0.55
$25.33
52 Week High
$5.78
$49.65

Technical Indicators

Market Signals
Indicator
IRWD
BBSI
Relative Strength Index (RSI) 68.15 43.44
Support Level $3.07 $28.11
Resistance Level $5.67 $29.49
Average True Range (ATR) 0.26 0.72
MACD 0.07 -0.03
Stochastic Oscillator 96.55 7.55

Price Performance

Historical Comparison
IRWD
BBSI

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.

Share on Social Networks: